5% STAKE4588.TTSECAYMAN ISLANDS

Evo Fund lowers stake in Oncolys BioPharma to 11.97%

Stake history

10%12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ
10%12%14%16%18%15.19%PriorPrior: 15.19% · prior ratio stated in S100U4FX13.49%Aug 1Aug 1: 13.49% · S100U4FX11.97%Aug 14Aug 14: 11.97% · S100U7QJ

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-14 10:52 JST concerning Oncolys BioPharma Inc. Reported holding ratio: 11.97%, previous report: 13.49%.

Open the price chart on TradingView.

Source: EDINET S100U7QJ ↗ · PDL1.0 · Not investment advice